213 related articles for article (PubMed ID: 25286334)
1. Perspectives on percutaneous penetration: Silica nanoparticles.
Nafisi S; Schäfer-Korting M; Maibach HI
Nanotoxicology; 2015; 9(5):643-57. PubMed ID: 25286334
[TBL] [Abstract][Full Text] [Related]
2. Penetration of nanoparticles and nanomaterials in the skin: fiction or reality?
Baroli B
J Pharm Sci; 2010 Jan; 99(1):21-50. PubMed ID: 19670463
[TBL] [Abstract][Full Text] [Related]
3. The impact of skin massage frequency on the intrafollicular transport of silica nanoparticles: Validation of the ratchet effect on an ex vivo porcine skin model.
Busch L; Keziban Y; Dähne L; Keck CM; Meinke MC; Lademann J; Patzelt A
Eur J Pharm Biopharm; 2021 Jan; 158():266-272. PubMed ID: 33264667
[TBL] [Abstract][Full Text] [Related]
4. Analysis of Skin Permeability and Toxicological Properties of Amorphous Silica Particles.
Matsuo K; Hirobe S; Okada N; Nakagawa S
Biol Pharm Bull; 2016; 39(7):1201-5. PubMed ID: 27374294
[TBL] [Abstract][Full Text] [Related]
5. Effect of surface modification of silica nanoparticles on toxicity and cellular uptake by human peripheral blood lymphocytes in vitro.
Lankoff A; Arabski M; Wegierek-Ciuk A; Kruszewski M; Lisowska H; Banasik-Nowak A; Rozga-Wijas K; Wojewodzka M; Slomkowski S
Nanotoxicology; 2013 May; 7(3):235-50. PubMed ID: 22264124
[TBL] [Abstract][Full Text] [Related]
6. Silica-Based Nanoparticles for Biomedical Applications: From Nanocarriers to Biomodulators.
Yang Y; Zhang M; Song H; Yu C
Acc Chem Res; 2020 Aug; 53(8):1545-1556. PubMed ID: 32667182
[TBL] [Abstract][Full Text] [Related]
7. Silica nanoparticles: preparation, characterization and in vitro/in vivo biodistribution studies.
Tamba BI; Dondas A; Leon M; Neagu AN; Dodi G; Stefanescu C; Tijani A
Eur J Pharm Sci; 2015 Apr; 71():46-55. PubMed ID: 25681629
[TBL] [Abstract][Full Text] [Related]
8. In vitro evaluation of the internalization and toxicological profile of silica nanoparticles and submicroparticles for the design of dermal drug delivery strategies.
Vicente S; Moia C; Zhu H; Vigé X
J Appl Toxicol; 2017 Dec; 37(12):1396-1407. PubMed ID: 28744887
[TBL] [Abstract][Full Text] [Related]
9. Skin penetration and cellular uptake of amorphous silica nanoparticles with variable size, surface functionalization, and colloidal stability.
Rancan F; Gao Q; Graf C; Troppens S; Hadam S; Hackbarth S; Kembuan C; Blume-Peytavi U; Rühl E; Lademann J; Vogt A
ACS Nano; 2012 Aug; 6(8):6829-42. PubMed ID: 22797484
[TBL] [Abstract][Full Text] [Related]
10. Silica-based matrices: State of the art and new perspectives for therapeutic drug delivery.
Andreani T; Silva AM; Souto EB
Biotechnol Appl Biochem; 2015; 62(6):754-64. PubMed ID: 25471460
[TBL] [Abstract][Full Text] [Related]
11. Mesoporous systems for poorly soluble drugs.
Xu W; Riikonen J; Lehto VP
Int J Pharm; 2013 Aug; 453(1):181-97. PubMed ID: 22990124
[TBL] [Abstract][Full Text] [Related]
12. Intracellular degradation of multilabeled poly(ethylene imine)-mesoporous silica-silica nanoparticles: implications for drug release.
Bergman L; Kankaanpää P; Tiitta S; Duchanoy A; Li L; Heino J; Lindén M
Mol Pharm; 2013 May; 10(5):1795-803. PubMed ID: 23510188
[TBL] [Abstract][Full Text] [Related]
13. Impact of structural differences in hyperbranched polyglycerol–polyethylene glycol nanoparticles on dermal drug delivery and biocompatibility.
Kumar S; Alnasif N; Fleige E; Kurniasih I; Kral V; Haase A; Luch A; Weindl G; Haag R; Schäfer-Korting M; Hedtrich S
Eur J Pharm Biopharm; 2014 Nov; 88(3):625-34. PubMed ID: 25445303
[TBL] [Abstract][Full Text] [Related]
14. Toxicity assessment of silica nanoparticles, functionalised silica nanoparticles, and HASE-grafted silica nanoparticles.
Clément L; Zenerino A; Hurel C; Amigoni S; Taffin de Givenchy E; Guittard F; Marmier N
Sci Total Environ; 2013 Apr; 450-451():120-8. PubMed ID: 23474257
[TBL] [Abstract][Full Text] [Related]
15. Nanoparticles in targeted cancer therapy: mesoporous silica nanoparticles entering preclinical development stage.
Rosenholm JM; Mamaeva V; Sahlgren C; Lindén M
Nanomedicine (Lond); 2012 Jan; 7(1):111-20. PubMed ID: 22191780
[TBL] [Abstract][Full Text] [Related]
16. Skin penetration of silica microparticles.
Boonen J; Baert B; Lambert J; De Spiegeleer B
Pharmazie; 2011 Jun; 66(6):463-4. PubMed ID: 21699089
[TBL] [Abstract][Full Text] [Related]
17. State of the Art of Silica Nanoparticles: An Overview on Biodistribution and Preclinical Toxicity Studies.
Yu J; Dan N; Eslami SM; Lu X
AAPS J; 2024 Mar; 26(3):35. PubMed ID: 38514482
[TBL] [Abstract][Full Text] [Related]
18. Topical delivery of cosmetics and drugs. Molecular aspects of percutaneous absorption and delivery.
Förster M; Bolzinger MA; Fessi H; Briançon S
Eur J Dermatol; 2009; 19(4):309-23. PubMed ID: 19443302
[TBL] [Abstract][Full Text] [Related]
19. Improved percutaneous delivery of ketoprofen using combined application of nanocarriers and silicon microneedles.
Vučen SR; Vuleta G; Crean AM; Moore AC; Ignjatović N; Uskoković D
J Pharm Pharmacol; 2013 Oct; 65(10):1451-62. PubMed ID: 24028612
[TBL] [Abstract][Full Text] [Related]
20. Penetration and storage of particles in human skin: perspectives and safety aspects.
Lademann J; Richter H; Schanzer S; Knorr F; Meinke M; Sterry W; Patzelt A
Eur J Pharm Biopharm; 2011 Apr; 77(3):465-8. PubMed ID: 21056659
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
